IL2 and amyotrophic lateral sclerosis: Indeed, this study showed that percentages of NK cells were increased in ALS patients, and unlike those obtained from either the identical twin or those of the other healthy controls, their cytotoxic function did not decrease when treated with IL-2 + anti-CD16 mAbs (Figure 2a,b).